Alterity Therapeutics Limited - Depositary Receipt (Common Stock) (ATHE)
Market Closed
27 Jul, 20:00
$
4. 67
+0.12
+2.7533%
$
41.15M Market Cap
- P/E Ratio
- Div Yield
4,031 Volume
0 Eps
$ 4.54
Previous Close 
Want to track ATHE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alterity Therapeutics Limited (ATHE) Discusses Phase II Data and Development Strategy for ATH434 in Multiple System Atrophy Transcript
Alterity Therapeutics Limited (ATHE) Discusses Phase II Data and Development Strategy for ATH434 in Multiple System Atrophy Transcript
Seekingalpha | 3 months ago
Alterity (ATHE) Up on Interim Data From Advance MSA Study
Alterity (ATHE) posts positive interim data from the phase II ATH434-202 study evaluating its lead candidate ATH434 for treating patients with multiple system atrophy. Stock rises.
Zacks | 2 years ago
